SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Currax’s Derrick Gastineau discusses the drugmaker’s recently-launched Real Patients, Real Results campaign and its position in the weight loss market.

Maternal health advocates say they’re working together to bring national attention to the potential funding threat to ERASE MM. Griffen, the executive director of the Maternal Mental Health Leadership ...

Burson reported a slight acceleration in like-for-like revenue decline in Q2, although there was positive news on new ...

The new law imposes additional paperwork requirements on Obamacare enrollees, slashes the time they have each year to sign up and cuts funding for navigators who help them shop for plans.

AbbVie’s Skyrizi tallied the most TV impressions among pharma brands in July, rising from second in June. The psoriasis treatment achieved a share of voice (SOV) of 4.61% with 2.5 billion impressions.

Veterans hospitals are struggling to replace hundreds of doctors and nurses who have left the healthcare system this year.

Veterans hospitals are struggling to replace hundreds of doctors and nurses who have left the healthcare system this year. Get to know each of these companies by learning about their culture, ...

As mRNA falls out of favor for HHS, are cancer vaccines next? White House talks to drugmakers about raising prices abroad ...

Propel Health Communications, a 2025 MM+M Agency 100 honoree, hired Christopher Thorn as SVP, creative director and Lauren ...

Novavax expects post-marketing COVID study to cost up to $90M; New Novo CEO set to reallocate struggling drugmaker’s resources; WSJ editorial board argues against Trump’s MFN proposal.